Zakaria El Kebbaj, Pierre Andreoletti, Driss Mountassif, Mostafa Kabine, Hervé Schohn, Michel Dauça, Norbert Latruffe, M'hammed Saïd El Kebbaj, Mustapha Cherkaoui-Malki
Index: Endocrinology 150(3) , 1192-201, (2009)
Full Text: HTML
Seasonal obesity and fasting-associated hibernation are the two major metabolic events governing hepatic lipid metabolism in hibernating mammals. In this process, however, the role of the nuclear receptor known as peroxisome proliferator-activated receptor (PPAR)-alpha has not been elucidated yet. Here we show, as in human, that jerboa (Jaculus orientalis) liver expresses both active wild-type PPARalpha (PPARalpha1wt) and truncated PPARalpha forms and that the PPARalpha1wt to truncated PPARalpha2 ratio, which indicates the availability of active PPARalpha1wt, is differentially regulated during fasting-associated hibernation. Functional activation of hepatic jerboa PPARalpha, during prehibernating and hibernating states, was demonstrated by the induction of its target genes, which encode peroxisomal proteins such as acyl-CoA oxidase 1, peroxisomal membrane protein 70, and catalase, accompanied by a concomitant induction of PPARalpha thermogenic coactivator PPARgamma coactivator-1alpha. Interestingly, sustained activation of PPARalpha by its hypolipidemic ligand, ciprofibrate, abrogates the adaptive fasting response of PPARalpha during prehibernation and overinduces its target genes, disrupting the prehibernation fattening process. In striking contrast, during fasting-associated hibernation, jerboas exhibit preferential up-regulation of hepatic peroxisomal fatty acid oxidation instead of the mitochondrial pathway, which is down-regulated. Taken together, our results strongly suggest that PPARalpha is subject to a hibernation-dependent splicing regulation in response to feeding-fasting conditions, which defines the activity of PPARalpha and the activation of its target genes during hibernation bouts of jerboas.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Ciprofibrate
CAS:52214-84-3 |
C13H14Cl2O3 |
Transcriptional Regulation of Cytosolic Sulfotransferase 1C2...
2015-12-01 [J. Pharmacol. Exp. Ther. 355 , 429-41, (2015)] |
Ciprofibrate increases cholesteryl ester transfer protein ge...
2009-01-01 [Lipids Health Dis. 8 , 50, (2009)] |
Ciprofibrate, clofibric acid and respective glycinate deriva...
2008-01-01 [Arzneimittelforschung 58(5) , 225-41, (2008)] |
Species-specific kinetics and zonation of hepatic DNA synthe...
2008-07-01 [Toxicol. Sci. 104(1) , 74-85, (2008)] |
The atherogenic role of triglycerides and small, dense low d...
1996-07-01 [Atherosclerosis 124 Suppl , S21-8, (1996)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved